transforming-growth-factor-beta has been researched along with Gastrointestinal-Stromal-Tumors* in 2 studies
2 other study(ies) available for transforming-growth-factor-beta and Gastrointestinal-Stromal-Tumors
| Article | Year |
|---|---|
ASO Author Reflections: Nodal Disease Burden in Patients with Gastrointestinal Stromal Tumor.
Topics: Cost of Illness; Gastrointestinal Stromal Tumors; Humans; Transforming Growth Factor beta | 2022 |
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
Avoiding destruction by immune cells is a hallmark of cancer, yet how tumors ultimately evade control by natural killer (NK) cells remains incompletely defined. Using global transcriptomic and flow-cytometry analyses and genetically engineered mouse models, we identified the cytokine-TGF-β-signaling-dependent conversion of NK cells (CD49a Topics: Animals; Case-Control Studies; Cell Line, Tumor; Cellular Reprogramming; Enzyme-Linked Immunosorbent Assay; Fibrosarcoma; Flow Cytometry; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Humans; Immunity, Innate; Killer Cells, Natural; Lymphocytes; Mice; Neoplasms, Experimental; Sequence Analysis, RNA; Signal Transduction; Transforming Growth Factor beta; Tumor Escape | 2017 |